StockWatch
·
 Medicinal Chemicals and Botanical Products
Corporate ActionMay 1, 2026, 05:26 PM

22nd Century Group to Sell $6.4M Common Stock via Sales Agreement

AI Summary

22nd Century Group, Inc. filed a prospectus supplement on May 1, 2026, enabling the sale of $6,400,000 shares of its common stock. This offering will be conducted through its amended sales agreement with Needham & Company, LLC. As of the filing date, the company had 4,455,649 shares of common stock outstanding and had not sold any shares under this agreement in the prior 12 months.

Key Highlights

  • Filed prospectus supplement to sell $6,400,000 shares of common stock.
  • Offering to be conducted through amended sales agreement with Needham & Company, LLC.
  • 4,455,649 shares of common stock outstanding as of May 1, 2026.
  • No shares sold under the sales agreement in the prior 12 months.